Article Details
Retrieved on: 2022-05-01 18:48:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
Article found on: finnewslive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here